Stark, D., Nankivell, M., Pujade-Lauraine, E., Kristensen, G., Elit, L., Stockler, M., . . . Perren, T. (2013). Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: Quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial. Lancet Pub. Group.
Styl cytowania ChicagoStark, Dan, et al. Standard Chemotherapy With or Without Bevacizumab in Advanced Ovarian Cancer: Quality-of-life Outcomes From the International Collaboration On Ovarian Neoplasms (ICON7) Phase 3 Randomised Trial. Lancet Pub. Group, 2013.
Styl cytowania MLAStark, Dan, et al. Standard Chemotherapy With or Without Bevacizumab in Advanced Ovarian Cancer: Quality-of-life Outcomes From the International Collaboration On Ovarian Neoplasms (ICON7) Phase 3 Randomised Trial. Lancet Pub. Group, 2013.